This is a preview of subscription content, log in via an institution to check access.
Notes
Canadian dollars (2011 values)
Reference
Coyle D, et al. Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation. Value in Health 16: 498-506, No. 4, Jun 2013. Available from: URL: http://dx.doi.org/10.1016/j.jval.2013.01.009
Rights and permissions
About this article
Cite this article
Patient characteristics a key factor in CEA of NOACs. PharmacoEcon Outcomes News 682, 9 (2013). https://doi.org/10.1007/s40274-013-0549-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0549-5